For over 16 years, we have become the most professional manufacturer in the world, No.1 in China in the methylfolate industry. With strict quality guarantee system, strong brand awareness and high-level after sale service, our company is famous for the business philosophy “Only manufacture and supply premium quality products.”
Methylfolate, the active form of folic acid, plays a role in converting homocysteine into methionine (a harmless amino acid), so if methylfolate is lacking due to the MTHFR mutation and subsequent inability to convert folic acid to methylfolate, homocysteine can build up to dangerous levels.
Usually, the recommend dosage of folic acid is 400mcg per day. While, it has been proven that the unmetabolized folic acid (UMFA) will appear when you take the folic acid 200mcg per day. And many studies have shown that UMFA would participate in the circulation of the body's various organs with the blood, thus would cause many health problems, such as abnormal pregnancy, cancer, and leukemia. Also, if you have a MTHFR gene defect, you can’t convert the folic acid at all. (30% people has the MTHFR gene defect globally)
New form of folic acid (Calcium L-methyltetrahydrofolate) approved by the EU for use in Infant Nutrition (and follow-on formulas and baby foods).
As we all known, pregnancy women are advised to take supplements containing 400 or even 800 µg folate to decrease the risk of neural tube deformity. So, which kind of folate source should you choose? Actually, there are two kinds of folate source, folic acid and active folate L-5-Methyltetrahydrofolate. If you are using folic acid, it’s time to change!
Do you know that EU has approved the L-5-MTHF Ca to be used in infant formula and follow-on formula? Quite a good news! It means our infants can enjoy the much safer active folate source methylfolate. You can add the methylfolate in your infant formula milk powder. Trust Magnafolate will be your perfect choice.
There will be 1 case of dementia around the world every 3 seconds. About 50 million people suffer from dementia worldwide in 2018. And this number will increase to 152 million by 2050, three times as many cases as now. It is estimated that global cost of social dementia is $1 trillion in 2018, and the figure will rise to $2 trillion by 2030.
Copyright © 2021 Lianyungang Jinkang Hexin Pharmaceutical Co.,Ltd. All Rights Reserved jinkang-chem